JPM vs RMBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
RMBI presents a compelling value opportunity, trading at a discount to both its book value (P/B 0.97) and its Graham Number ($19.91). While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company exhibits robust growth with a 45% YoY increase in earnings. The significant gap between the current price ($14.55) and the growth-based intrinsic value ($34.52) suggests substantial upside potential. Despite a bearish technical trend score, the fundamental valuation and sustainable dividend yield provide a strong margin of safety.
Compare Another Pair
Related Comparisons
JPM vs RMBI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Richmond Mutual Bancorporation, Inc. (RMBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.